Physician

Maher Mark Awar, M.D.

According to 2025 Medicare claims, Maher Awar, M.D. (NPI: 1124052154) practices cardiology in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is YOUNG HEARTS OF YUMA, INC (NPI: 1396978268; TIN: 204373472) and primary practice location at 85364-6912.

Awar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,451 traditional Medicare patients, billed 15,368 HCPCS/CPT codes, and received $1,030,138 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 4,239 prescription claims across 883 beneficiaries totaling $696,203 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 24 claims. Open Payments data shows 16 records totaling $649. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,143,409 and ending at $1,030,138. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $435,444 to $696,203. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $14,052 to $17,028.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,685	16,521	$1,143,409
2016	1,455	11,497	$952,231
2017	1,278	10,559	$892,074
2018	1,294	10,328	$880,334
2019	1,937	17,140	$1,480,197
2020	1,536	11,326	$1,046,101
2021	1,399	11,122	$1,040,740
2022	1,542	15,813	$1,339,145
2023	1,506	16,026	$1,274,457
2024	1,451	15,368	$1,030,138

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	857	6,553	$435,444
2016	864	6,182	$531,610
2017	932	6,380	$570,804
2018	1,008	6,308	$664,762
2019	1,122	7,619	$942,552
2020	1,048	7,492	$1,033,082
2021	1,076	7,285	$1,056,755
2022	1,056	6,710	$1,052,282
2023	971	5,679	$944,988
2024	883	4,239	$696,203

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	59	$6,391
2016	N/R	24	$1,468
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	365	375	$322
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	766	819	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	913	1,836	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	847	1,522	$60
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,015	1,587	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	220	16,412	$306,362
Entresto	Sacubitril/Valsartan	66	5,080	$99,927
Repatha Sureclick	Evolocumab	91	4,290	$82,419
Xarelto	Rivaroxaban	38	2,520	$45,882
Farxiga	Dapagliflozin Propanediol	17	1,470	$25,441

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$649	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maher Mark Awar, M.D.?

Tedicare shows public-source Medicare data for Maher Mark Awar, M.D. (NPI 1124052154), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maher Mark Awar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maher Mark Awar, M.D.?

Maher Mark Awar, M.D. is linked to YOUNG HEARTS OF YUMA, INC (billing NPI 1396978268) in the available physician profile data.

Does Maher Mark Awar, M.D. have Open Payments data?

Maher Mark Awar, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.